NHC exec awarded 14,000 stock options

NATIONAL HEALTHCARE CORP reported that Sr.

Accepted by SEC EDGAR 02/25/2026 - 05:10 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP reported that Sr. VP of Operations Timothy J. Shelly received a grant of stock options to purchase 14,000 shares of common stock on February 23, 2026. The options were granted at an exercise price reported as $0.0000 per share.

The options were issued under the company’s 2020 Omnibus Equity Incentive Plan and will vest ratably over three years. One-third will vest on February 23, 2027, another one-third on February 23, 2028, and the final one-third on February 23, 2029, after which they become exercisable.

Insider Trade Summary

Grant/Award: 14,000 shares

Grant/Award 1 txn

Insider Shelly Timothy J.

Role Sr.VP Operations

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	14,000	$0.00	$0.00
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Option to Purchase Common Stock — 35,400 contracts for 21,400 underlying shares (Direct); Common Stock — 0 shares (Direct)

Footnotes (2)

1. F1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
2. F2. These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the NHC Form 4 filing report for Timothy J. Shelly?

The Form 4 for NHC shows Sr. VP of Operations Timothy J. Shelly was granted options to purchase 14,000 shares of common stock. The grant occurred on February 23, 2026 under the company’s 2020 Omnibus Equity Incentive Plan.

How many stock options were granted to the NHC executive and at what price?

Timothy J. Shelly received 14,000 stock options to purchase NATIONAL HEALTHCARE CORP common stock. The filing reports an exercise price of $0.0000 per share, indicating the options were granted without a stated purchase cost in the transaction data.

What is the vesting schedule for Timothy J. Shelly’s NHC stock options?

The 14,000 stock options granted to Timothy J. Shelly vest ratably over three years. One-third vests on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029, after which each vested portion becomes exercisable.

Under which plan were the NHC stock options to Timothy J. Shelly granted?

The options granted to Timothy J. Shelly were issued under NATIONAL HEALTHCARE CORP’s 2020 Omnibus Equity Incentive Plan. The footnotes state the grant occurred on February 23, 2026 and that the grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).

Does the NHC Form 4 indicate any stock sales by Timothy J. Shelly?

The Form 4 for NHC reports a grant or award acquisition of 14,000 stock options to Timothy J. Shelly and classifies it as an acquisition transaction. The summarized transaction data show no reported stock sales or disposition transactions in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shelly Timothy J.

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr.VP Operations

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	2,400		2,400	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	11,000		11,000	D
Option to Purchase Common Stock	$157.13	02/23/2026		A		14,000(1)		02/24/2027(2)	02/24/2031	Common Stock	14,000	$0	14,000	D

Explanation of Responses:

1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

2. These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.

	/s/ Timothy J. Shelly	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.